Skip to main content
. 2017 Mar 28;8(18):30383–30394. doi: 10.18632/oncotarget.16628

Figure 6.

Figure 6

The frequency of CD4+ TH17 cells (A) was measured in both control individuals and MM and MGUS patients. The percentage expression of CXCR3 (B) and CCR4 (C) was then determined on the CD4+ TH17 cells within these compartments. Statistical analysis was by Kruskal Wallis where *** = p < 0.001, ** = p < 0.01, * p < 0.05